QT-PINE SR 200: Exploring Quetiapine Prolonged Release (200mg)

Quetiapine Prolonged Release (200mg) & QT-PINE SR 200 

Quetiapine Prolonged Release, available under the brand name QT-PINE SR 200, is a medication prescribed for various psychiatric conditions. With its sustained-release formulation delivering 200mg of Quetiapine, QT-PINE SR 200 offers a convenient and effective treatment option for patients requiring long-term management of their symptoms. This comprehensive guide delves into the uses, dosage guidelines, benefits, potential side effects, and other essential considerations associated with QT-PINE SR 200.

Understanding QT-PINE SR 200:

1. Sustained Release Formulation:

QT-PINE SR 200 features a prolonged-release formulation of Quetiapine, ensuring a gradual and sustained delivery of the medication over an extended period. This sustained release profile allows for once-daily dosing, providing consistent symptom control and improving patient adherence compared to immediate-release formulations.

2. Therapeutic Uses:

QT-PINE SR 200 is primarily prescribed for the treatment of schizophrenia and bipolar disorder. It is also indicated for the management of depressive episodes in bipolar disorder and adjunctive treatment of major depressive disorder. Quetiapine, the active ingredient in QT-PINE SR 200, acts as an antagonist at multiple neurotransmitter receptors, including dopamine and serotonin receptors, to alleviate symptoms of psychosis and mood disorders.

3. Dosage Guidelines:

The recommended starting dose of QT-PINE SR 200 for schizophrenia is typically 50mg once daily, with gradual titration as tolerated to a target dose of 300-800mg daily. For bipolar disorder, the initial dose may range from 50mg to 100mg once daily, with adjustments made based on individual response. Dosage adjustments should be made under the guidance of a healthcare provider.

4. Benefits of Prolonged Release:

QT-PINE SR 200 offers several advantages over immediate-release formulations. The prolonged-release profile ensures a steady and consistent blood concentration of Quetiapine, minimizing fluctuations and providing continuous symptom relief throughout the day. This can result in improved tolerability and reduced risk of certain side effects associated with rapid changes in drug concentration.

5. Potential Side Effects:

Some patients may experience metabolic changes, such as elevated cholesterol or triglyceride levels. Rare but serious side effects include orthostatic hypotension, tardive dyskinesia, and neuroleptic malignant syndrome. 

Conclusion:

In conclusion, QT-PINE SR 200 offers a convenient and effective treatment option for individuals with schizophrenia and bipolar disorder. Its prolonged-release formulation provides continuous symptom control and improved patient adherence compared to immediate-release formulations. However, like all medications, QT-PINE SR 200 carries potential risks and side effects that should be carefully considered and monitored. Patients should work closely with their healthcare provider to determine if QT-PINE SR 200 is the right treatment option for their psychiatric condition. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW